| Mrs Ruth Carpio, MA, CF-SLP, TSSLD | |
|
9110 146th St, Jamaica, NY 11435-4301 | |
| (718) 468-9000 | |
| Not Available |
| Full Name | Mrs Ruth Carpio |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 9110 146th St, Jamaica, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144585647 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ruth Carpio, MA, CF-SLP, TSSLD 9215 217th St, Queens Village, NY 11428-1253 Ph: (646) 546-7936 | Mrs Ruth Carpio, MA, CF-SLP, TSSLD 9110 146th St, Jamaica, NY 11435-4301 Ph: (718) 468-9000 |
News Archive
Two separate new studies presented at a major medical meeting provide objective scientific evidence that the two most commonly performed cartilage repair techniques are effective at restoring patient mobility and reducing pain.
US-Australian drug discovery company, Novogen Limited announced today that its candidate cytotoxic chemotherapy drug, Anisina, has proved an effective anti-cancer agent in animals, the result of which it now has been fast-tracked by the Company to come into the clinic.
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for the company's MA09-hRPE cells for use in the treatment of Stargardt's Macular Dystrophy (SMD). As a result, the company is eligible to receive a number of benefits, including tax credits, access to grant funding for clinical trials, accelerated FDA approval and allowance for marketing exclusivity after drug approval for a period of as long as seven years.
According to new research that will receive the Graduate Student Research Award on Saturday, June 5, at the 19th Annual Meeting of the American Academy of Dental Sleep Medicine, the ratio between tongue volume and bony enclosure size in patients with obstructive sleep apnea may help dentists calculate oral appliance treatment success.
› Verified 3 days ago
Tsipora Mishaely, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 18635 80th Dr, Jamaica, NY 11432 Phone: 917-244-4161 | |
Richard Muller, MS SLP TSSLD Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 9110 146th St, Jamaica, NY 11435 Phone: 718-468-9000 | |
Laurie Ann Hernandez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8422 Midland Pkwy, Jamaica, NY 11432 Phone: 917-597-6920 | |
Elizabeth Barrett Ryan, MA, CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8516 Somerset St, Jamaica, NY 11432 Phone: 917-817-0836 Fax: 718-657-1208 | |
Janine Dominguez, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10959 Inwood St, Jamaica, NY 11435 Phone: 718-526-5523 Fax: 718-526-8191 | |
Cassandra Dantzler, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12520 Sutphin Blvd, Jamaica, NY 11434 Phone: 718-558-2900 Fax: 718-925-9020 | |
Lena Layne, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 17603 Croydon Rd, Jamaica, NY 11432 Phone: 718-526-1364 |